Susquehanna Fundamental Investments, LLC Ionis Pharmaceuticals Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $6.94 Billion
- Q1 2025
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 158,609 shares of IONS stock, worth $6.33 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
158,609
Previous 213,015
25.54%
Holding current value
$6.33 Million
Previous $7.45 Million
35.75%
% of portfolio
0.07%
Previous 0.11%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$654 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$646 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$494 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$412 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$336 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.67B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...